Keyphrases
Ageratum Conyzoides
100%
Aggrecan
16%
Anti-inflammatory Activity
100%
Cartilage Injury
16%
Collagen Type II
16%
Core Protein
16%
Diclofenac
16%
Disease Treatment
16%
Disintegrin
16%
Edema
33%
Enzyme-linked Immunosorbent Assay (ELISA)
16%
Group Treatment
33%
Indonesia
16%
Inducible Nitric Oxide Synthase
33%
Inflammatory Process
33%
Injection Dose
16%
Interleukin-1β
33%
Intra-articular
16%
Joint Disease
16%
Knee
33%
Matrix Metalloproteinase 13 (MMP13)
16%
Metalloproteinases
16%
Monosodium Iodoacetate
66%
Nanogel
100%
Negative Control
16%
New Drugs
16%
Oldenlandia Corymbosa
100%
Osteoarthritis
33%
Physical Characteristics
33%
Plant Natural Products
16%
Positive Control
16%
Potential Therapeutics
16%
S100A8 Protein
33%
Serum Cytokine Level
33%
Thrombospondin-1 (TSP-1)
16%
Topical Preparation
33%
Traditional Medicine
16%
Zero-day
16%
Pharmacology, Toxicology and Pharmaceutical Science
Ageratum Conyzoides
100%
Aggrecan
16%
Anti-Inflammatory Drug
100%
Arthropathy
16%
Biological Marker
33%
Calgranulin A
33%
Collagen Type 2
16%
Collagenase 3
16%
Core Protein
16%
Cytokine
33%
Diclofenac
16%
Disease
16%
Disintegrin
16%
Edema
33%
Inducible Nitric Oxide Synthase
33%
Inflammation
33%
Interleukin 1
16%
Iodoacetic Acid
66%
Metalloproteinase
16%
Natural Product
16%
Oldenlandia
100%
Osteoarthritis
33%
Thrombospondin
16%